ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Dakota » Hematology Oncology

Top Hematology Oncology Prescribers in North Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GERALD GROSS MD

Hematology Oncology

1,563

$830K

156
141 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 17%

$531
Average prescription price

Avg: $417

MAHENDRA GUPTA MD

Hematology Oncology

1,296

$521K

220
183 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 17%

$402
Average prescription price

Avg: $417

DANIEL WALSH MD

Hematology Oncology

1,188

$467K

162
149 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 17%

$393
Average prescription price

Avg: $417

KEVIN PANICO MD

Hematology Oncology

1,158

$361K

161
145 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 17%

$312
Average prescription price

Avg: $417

AMIT PANWALKAR

Hematology Oncology

1,050

$337K

176
157 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 17%

$321
Average prescription price

Avg: $417

FERDINAND ADDO MD

Hematology Oncology

964

$365K

99
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 17%

$379
Average prescription price

Avg: $417

STEPHEN MAKONI MD

Hematology Oncology

892

$277K

142
126 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 17%

$310
Average prescription price

Avg: $417

MATTHEW THOMAS MD

Hematology Oncology

806

$513K

116
106 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 17%

$636
Average prescription price

Avg: $417

JAYARAM BHARADWAJ M.D.

Hematology Oncology

781

$159K

147
131 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

18%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 17%

$204
Average prescription price

Avg: $417

EDWARD WOS DO

Hematology Oncology

623

$400K

103
89 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 17%

$642
Average prescription price

Avg: $417

JOHN REYNOLDS MD

Hematology Oncology

560

$307K

93
84 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 17%

$549
Average prescription price

Avg: $417

PAUL FREIBERG MD

Hematology Oncology

554

$226K

83
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

17%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 17%

$408
Average prescription price

Avg: $417

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank